In addition to the essential knowledge of whether the patient's tumor expresses ER, PR, or HER2, the tumor (or tumors) size, lymph node stage and histological grade of disease are critical and may determine whether or not the patient will receive chemotherapy. This evidence concerns the gene ESR1 and neoplasm.